ALCBX
Price
$12.71
Change
+$0.04 (+0.32%)
Updated
Jul 25 closing price
Net Assets
12.34M
RLEFX
Price
$37.17
Change
+$0.07 (+0.19%)
Updated
Jul 25 closing price
Net Assets
254.37B
Interact to see
Advertisement

ALCBX vs RLEFX

Header iconALCBX vs RLEFX Comparison
Open Charts ALCBX vs RLEFXBanner chart's image
ALPS/Smith Balanced Opportunity C
Price$12.71
Change+$0.04 (+0.32%)
VolumeN/A
Net Assets12.34M
American Funds American Balanced R5E
Price$37.17
Change+$0.07 (+0.19%)
VolumeN/A
Net Assets254.37B
ALCBX vs RLEFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ALCBX vs. RLEFX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALCBX is a StrongBuy and RLEFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLEFX has more cash in the bank: 254B vs. ALCBX (12.3M). RLEFX pays higher dividends than ALCBX: RLEFX (2.01) vs ALCBX (0.88). ALCBX was incepted earlier than RLEFX: ALCBX (5 years) vs RLEFX (10 years). ALCBX (3.33) is less costly to investors than RLEFX (0.39). ALCBX is a more actively managed with annual turnover of: 131.00 vs. RLEFX (44.00). RLEFX has a lower initial minimum investment than ALCBX: RLEFX (250) vs ALCBX (2500). RLEFX annual gain was more profitable for investors over the last year : 10.46 vs. ALCBX (1.59).
ALCBXRLEFXALCBX / RLEFX
Total Expense Ratio1.850.39474%
Annual Report Gross Expense Ratio3.330.39854%
Fund Existence5 years10 years-
Gain YTD5.6029.13361%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.3M254B0%
Annual Yield % from dividends0.882.0143%
Returns for 1 year1.5910.4615%
Returns for 3 years25.6335.4272%
Returns for 5 yearsN/A40.77-
Returns for 10 years12.90N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SVRA2.580.03
+1.18%
Savara
WEX175.621.52
+0.87%
WEX
CGON26.10-0.04
-0.15%
CG Oncology
LFVN13.71-0.27
-1.93%
Lifevantage Corp
ISPC1.07-0.03
-2.79%
iSpecimen Inc